Dewan Sukriti, McCabe Kimberly J, Regnier Michael, McCulloch Andrew D
Departments of Bioengineering and Medicine, University of California San Diego, La Jolla, CA, USA.
Departments of Bioengineering and Medicine, University of Washington Seattle, WA, USA.
Front Physiol. 2017 Mar 14;8:151. doi: 10.3389/fphys.2017.00151. eCollection 2017.
Dilated Cardiomyopathy (DCM) is a leading cause of sudden cardiac death characterized by impaired pump function and dilatation of cardiac ventricles. In this review we discuss various approaches to elucidating the mechanisms of genetic mutations leading to DCM. The approaches covered in this review focus on bridging the spatial and temporal gaps that exist between molecular and cellular processes. Mutations in sarcomeric regulatory thin filament proteins such as the troponin complex (cTn) and Tropomyosin (Tm) have been associated with DCM. Despite the experimentally-observed myofilament measures of contractility in the case of these mutations, the mechanisms by which the underlying molecular changes and protein interactions scale up to organ failure by these mutations remains elusive. The review highlights multi-scale modeling approaches and their applicability to study the effects of sarcomeric gene mutations . We discuss some of the insights that can be gained from computational models of cardiac biomechanics when scaling from molecular states to cellular level.
扩张型心肌病(DCM)是心源性猝死的主要原因,其特征是泵功能受损和心室扩张。在本综述中,我们讨论了阐明导致DCM的基因突变机制的各种方法。本综述涵盖的方法侧重于弥合分子和细胞过程之间存在的时空差距。肌节调节细肌丝蛋白的突变,如肌钙蛋白复合体(cTn)和原肌球蛋白(Tm),已与DCM相关联。尽管在这些突变情况下通过实验观察到了肌丝收缩性的测量结果,但这些突变导致潜在分子变化和蛋白质相互作用如何扩大到器官衰竭的机制仍不清楚。本综述强调了多尺度建模方法及其在研究肌节基因突变影响方面的适用性。我们讨论了从心脏生物力学计算模型从分子状态扩展到细胞水平时可以获得的一些见解。